Inventor · disambiguated record
Jacob Rajfer
Also filed as: RAJFER JACOB
9 granted patents·13 pending applications·88 citations·filing 1994–2024
86Inventor score
Files withK L R M LLC8GONZALEZ-CADAVID NESTOR F2LOS ANGELES BIOMED RES INST2RAJFER JACOB2HARBOR UCLA RES & EDUCATION1
Top patents by PatentIndex Score
22 records- 0180US10426812B2Compositions and methods for the treatment of orthopedic ailmentsK L R M LLC·Filed 2017·Granted Oct 1, 2019·2 cites·11 claims
- 0277US5594032AAmelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNAFiled 1994·Granted Jan 14, 1997·61 cites·11 claims
- 0376US10973866B2Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunctionK L R M LLC·Filed 2019·Granted Apr 13, 2021·1 cites·5 claims
- 0466US2024398889A1Nutraceutical composition and method for the protection of human arterial endothelial cells from endothelial cell dysfunctionK L R M LLC·Filed 2024·Application pending·0 cites
- 0565US8426374B1Method for modifying myostatin expressionMAGEE THOMAS R·Filed 2007·Granted Apr 23, 2013·3 cites·16 claims
- 0665US8133903B2Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesGONZALEZ-CADAVID NESTOR F·Filed 2004·Granted Mar 13, 2012·3 cites·5 claims
- 0765US2020000811A1Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2019·Application pending·0 cites
- 0864US2024180995A1Nutraceutical composition and method for the protection of human arterial endothelial cells from endothelial cell dysfunctionK L R M LLC·Filed 2023·Application pending·0 cites
- 0963US10406196B2Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunctionK L R M LLC·Filed 2013·Granted Sep 10, 2019·1 cites·17 claims
- 1062US10792324B2Compositions and methods for the treatment of orthopedic ailmentsK L R M LLC·Filed 2020·Granted Oct 6, 2020·0 cites·11 claims
- 1162US2019381124A1Compositions and methods for the treatment of orthopedic ailmentsK L R M LLC·Filed 2019·Application pending·0 cites
- 1262US2014350021A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMED RES INST·Filed 2014·Application pending·0 cites
- 1361US2018318307A1Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesLOS ANGELES BIOMEDICAL RES INSTITUTE AT HARBO·Filed 2017·Application pending·0 cites
- 1461US2014200219A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMED RES INST·Filed 2014·Application pending·0 cites
- 1558US2017239257A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMEDICAL RES INST AT HARBOR- UCLA MEDICAL CENTER·Filed 2016·Application pending·0 cites
- 1653US6133281ANMDA receptor blockers in the therapy of urogenital diseaseHARBOR UCLA RES & EDUCATION·Filed 1997·Granted Oct 17, 2000·17 cites·3 claims
- 1752US12453509B2Optical coherence tomography based sperm detection method and devices and systems for performing the sameLUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER·Filed 2022·Granted Oct 28, 2025·0 cites·18 claims
- 1852US2012141454A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesGONZALEZ-CADAVID NESTOR F·Filed 2012·Application pending·0 cites
- 1947US2012093950A1Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occuring age related erectile dysfunctionRAJFER JACOB·Filed 2010·Application pending·0 cites
- 2044US2012121740A1Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunctionRAJFER JACOB·Filed 2011·Application pending·0 cites
- 2143US2020246414A1Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal systemKLRM LLC·Filed 2020·Application pending·0 cites
- 2234US2018078602A1Methods and compositions for extending the efficacy of phosphodiesterase inhibitors for treating erectile dysfunction, and compositions for inhibiting the onset and slowing the progression of erectile dysfunctionK L R M LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacob Rajfer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →